Ontario expanding third dose COVID-19 vaccine eligibility to 50+ in mid-December

Canada News News

Ontario expanding third dose COVID-19 vaccine eligibility to 50+ in mid-December
Canada Latest News,Canada Headlines
  • 📰 CTVNews
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 99%

Ontario will be expanding third dose COVID-19 vaccine eligibility in mid-December, allowing individuals aged 50 and up to get the booster shot.

Individuals in this age group will be able to book their appointments starting at 8 a.m. on Dec. 13 through the provincial vaccine portal or call centre, at a pharmacy or at their family doctor's office. Ontarians must wait at least six months after they get their second dose to get the booster.

A limited supply of single dose Johnson & Johnson COVID-19 vaccine will also be available as of Thursday for people who have had an allergy or cannot get a mRNA vaccine for a medical reason.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CTVNews /  🏆 1. in CA

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Ontario reports 959 new COVID-19 cases, seven more deathsOntario reports 959 new COVID-19 cases, seven more deaths
Read more »

Ontario reports 959 new COVID-19 cases, eight deathsOntario reports 959 new COVID-19 cases, eight deathsOntario is reporting 959 new COVID-19 cases and eight deaths on Thursday. 469 new cases are in people not fully vaccinated against COVID-19 and 61 people have an unknown vaccination status
Read more »

Union recommends Cargill’s new offer at Alberta meat-packing plant hit with large COVID-19 outbreakUnion recommends Cargill’s new offer at Alberta meat-packing plant hit with large COVID-19 outbreakIf workers accept the deal, it would avert a strike or a lockout that could begin as early as Monday
Read more »

Pfizer submits data on antiviral COVID-19 pill to Health Canada for reviewPfizer submits data on antiviral COVID-19 pill to Health Canada for reviewPfizer has submitted clinical data to Health Canada regarding an oral medication it is hoping can be used to treat mild to moderate cases of COVID-19 in adults.
Read more »



Render Time: 2025-03-15 17:26:21